Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
The monthly price is the all-in cost
Compounding this is the regulatory gap
It is much smoother if clients take advantage of the carrier offer to complete CAA RxDC reporting requirement on their behalf, rather than going through the process independently
market is still dominated by innovators like Novo Nordisk and Eli Lilly Patent protections and regulatory barriers delay generic entry Sun Pharma is focusing on future entry through innovation and specialty drugs However, this is expected to change in the coming years as patents expire and biosimilars gain approvals
US$ 25.31
US$ 21.62
US$ 28.36
US$ 22.63
US$ 25.38
US$ 28.01
